Sep 2026
Targeting of NLRP3 Gln624/Ser658 by Carabrone attenuates inflammatory diseases.
Results indicate that carabrone might act as a modulator of NLRP3 inflammasome activation across multiple inflammatory disease contexts.
Bin Jia, Abuduwaili Zulalai, Huai-Ping Tang et al.
· European Journal of Pharmaco... · 0 citations